Insilico Medicine moves its AI-discovered treatment for idiopathic pulmonary fibrosis into late-stage testing, marking an important step for the future of artificial intelligence in...
The company's €45 million expansion brings research, development, and GMP manufacturing together under one roof, helping accelerate the journey from scientific discovery to commercial...
The new research collaboration aims to combine scientific expertise and advanced discovery platforms to develop innovative medicines for patients worldwide
Indianapolis, Indiana, 25 June 2026...
Canadian Healthtech Company Works to Complete Financial Filings While Maintaining Focus on Digital Healthcare Innovation
Montreal, Quebec, 18 June 2026 – Premier Health of America...
ELRIG reveals keynote speakers as the industry prepares to explore the next generation of drug research and innovationÂ
London, United Kingdom, 11 June 2026 –...
